Roxadustat for bone and brain health in dialysis patients
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether roxadustat, a medicine for anemia, can also help with bone problems and mood or thinking issues in people on hemodialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old.
- You must be willing to sign a consent form.
- You must have end-stage kidney disease and have been on hemodialysis for at least 3 months.
- You cannot be pregnant or breastfeeding.
- You cannot have a current cancer diagnosis.
- You cannot have a history of certain blood disorders or anemia from causes other than kidney disease.
- You cannot have taken certain bone medications (like bone-building or bone-breaking drugs) in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether roxadustat can help improve heart health, nutrition, and reduce inflammation in people on hemodialysis. It may offer a new treatment option for anemia related to kidney disease.
This early-phase study tests whether RVX000222 is safe and effective in people with end-stage kidney disease who receive hemodialysis. If you join, you’ll be carefully monitored to see how your body responds and whether it changes kidney-related health measures.
This trial is for people with heart failure, chronic kidney disease, and low red blood cell counts (anemia). It examines how well the drug roxadustat helps over a long period by looking at medical records from people who have already taken it for more than a year.
This study tests roxadustat, a medicine that helps the body make more red blood cells, in children and teens with anemia caused by chronic kidney disease. It may help improve anemia and related blood counts, while also monitoring safety.
This trial tests whether roxadustat can improve kidney oxygen levels and anemia in people with diabetic kidney disease. It may help if you have anemia from kidney problems and are being considered for medicines like erythropoietin (EPO).
This trial tests an investigational drug called roxadustat to see if it can help people with a certain type of low-risk MDS who need frequent red blood cell transfusions. It's for patients who haven't responded to other anemia treatments.
Hear when a new Kidney Failure, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.